Cartesian Therapeutics RNAC
NASDAQ RNAC
$7.22 +0.01 (+0.14%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cartesian Therapeutics (RNAC) Accumulated Depreciation (2015 - 2016)

Updated

Cartesian Therapeutics' Accumulated Depreciation came in at $3.32 million for Q2 2016.

Analysis

Cartesian Therapeutics (RNAC) Accumulated Depreciation (2015 - 2016) Analysis & Trends

At the end of FY2015, Cartesian Therapeutics' Accumulated Depreciation was $2.93 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Cartesian Therapeutics 216.57 Mn 216.57 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 3.32 Mn
Dec 31, 2015 2.93 Mn
API Access

Cartesian Therapeutics Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=RNAC&period=max&api_key=YOUR_API_KEY